Key facts
- This page summarizes Jason E. Estes's Form 4 filing for Bank7 Corp. (BSVN).
- 11 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 18 Jul 2024, 17:56.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options Exercise
Sale
Options Exercise
Sale
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $37.00 to $37.66. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each price in the range.
Footnote F2
The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $36.00 to $36,61. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each price in the range.
Footnote F3
Includes 7,647 restricted stock units that vest in four equal installments on February 15, 2025, 2026, 2027, and 2028.
Footnote F4
Includes 5,872 restricted stock units. The original grant of 8,808 restricted stock units vests in eight equal installments on February 15, 2024, 2025, 2026, 2027, 2028, 2029, 2030, and 2031.
Footnote F5
Includes 3,750 restricted stock units. The original grant of 7,500 restricted stock units vests in four equal installments on December 17, 2022, 2023, 2024, and 2025.
Footnote F6
Includes 1,250 restricted stock units. The original grant of 5,000 restricted stock units vests in five equal installments on January 4, 2022, 2023, 2024, and 2025.
Footnote F7
Includes 800 restricted stock units. The original grant of 4,000 restricted stock units vests in five equal installments on January 6, 2021, 2022, 2023, 2024, and 2025.
Footnote F8
Represents a grant of 15,000 employee stock options that vested in four equal installments on September 20, 2018, 2019, 2020, and 2021.
Footnote F9
Represents a grant of 5,000 employee stock options that vest in four equal installments on January 4, 2022, 2023, 2024, and 2025.